TY - JOUR
T1 - Home Telemonitoring to Reduce Readmission of High-Risk Patients
T2 - a Modified Intention-to-Treat Randomized Clinical Trial
AU - Dawson, Nancy L.
AU - Hull, Bryan P.
AU - Vijapura, Priyanka
AU - Dumitrascu, Adrian G.
AU - Ball, Colleen T.
AU - Thiemann, Kay M.
AU - Maniaci, Michael J.
AU - Burton, M. Caroline
N1 - Funding Information:
All contributors to the manuscript meet authorship requirements (as below). Nancy L. Dawson, MD, and Colleen T. Ball had full access to all data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Nancy L. Dawson takes responsibility for the integrity of the work as a whole, from inception to published article.
Publisher Copyright:
© 2021, Society of General Internal Medicine.
PY - 2021/11
Y1 - 2021/11
N2 - Background: Home telemonitoring has been used with discharged patients in an attempt to reduce 30-day readmissions with mixed results. Objective: To assess whether home 30-day telemonitoring after discharge for patients at high risk of readmission would reduce readmissions or mortality. Design: Prospective, randomized controlled trial. Patients: We compared 30-day readmission rates and mortality for patients at high risk for readmission who received home telemonitoring versus standard care between November 1, 2014, and November 30, 2018, in 2 tertiary care hospitals. Interventions: The intervention group received home-installed equipment to measure blood pressure, heart rate, pulse oximetry, weight if heart failure was present, and glucose if diabetes was present. Results were transmitted daily and reviewed by a nurse. Both groups received standard care. Main Measures: The primary outcome was a composite end point of hospital readmission or death within 30 days after discharge. The secondary outcome was an emergency department visit within 30 days after discharge. Key Results: A total of 1380 participants (mean [SD] age, 66 [14] years; 722 [52.3%] men and 658 [47.7%] women) participated in this study. Using a modified intention-to-treat analysis, the risk of readmission or death within 30 days among patients at high readmission risk was 23.7% (137/578) in the control group and 18.2% (87/477) in the telemonitoring group (absolute risk difference, − 5.5% [95% CI, − 10.4 to − 0.6%]; relative risk, 0.77 [95% CI, 0.61 to 0.98]; P =.03). Emergency department visits occurred within 30 days after discharge in 14.2% (81/570) of patients in the control group and 8.6% (40/464) of patients in the telemonitoring group (absolute risk difference, − 5.6% [95% CI, − 9.4 to − 1.8%]; relative risk, 0.61 [95% CI, 0.42 to 0.87]; P =.005). Conclusions: Thirty days of postdischarge telemonitoring may reduce readmissions of high-risk patients. Trial Registration: ClinicalTrials.gov identifier: NCT02136186.
AB - Background: Home telemonitoring has been used with discharged patients in an attempt to reduce 30-day readmissions with mixed results. Objective: To assess whether home 30-day telemonitoring after discharge for patients at high risk of readmission would reduce readmissions or mortality. Design: Prospective, randomized controlled trial. Patients: We compared 30-day readmission rates and mortality for patients at high risk for readmission who received home telemonitoring versus standard care between November 1, 2014, and November 30, 2018, in 2 tertiary care hospitals. Interventions: The intervention group received home-installed equipment to measure blood pressure, heart rate, pulse oximetry, weight if heart failure was present, and glucose if diabetes was present. Results were transmitted daily and reviewed by a nurse. Both groups received standard care. Main Measures: The primary outcome was a composite end point of hospital readmission or death within 30 days after discharge. The secondary outcome was an emergency department visit within 30 days after discharge. Key Results: A total of 1380 participants (mean [SD] age, 66 [14] years; 722 [52.3%] men and 658 [47.7%] women) participated in this study. Using a modified intention-to-treat analysis, the risk of readmission or death within 30 days among patients at high readmission risk was 23.7% (137/578) in the control group and 18.2% (87/477) in the telemonitoring group (absolute risk difference, − 5.5% [95% CI, − 10.4 to − 0.6%]; relative risk, 0.77 [95% CI, 0.61 to 0.98]; P =.03). Emergency department visits occurred within 30 days after discharge in 14.2% (81/570) of patients in the control group and 8.6% (40/464) of patients in the telemonitoring group (absolute risk difference, − 5.6% [95% CI, − 9.4 to − 1.8%]; relative risk, 0.61 [95% CI, 0.42 to 0.87]; P =.005). Conclusions: Thirty days of postdischarge telemonitoring may reduce readmissions of high-risk patients. Trial Registration: ClinicalTrials.gov identifier: NCT02136186.
KW - communication
KW - risk assessment
KW - telemedicine
UR - http://www.scopus.com/inward/record.url?scp=85099936557&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099936557&partnerID=8YFLogxK
U2 - 10.1007/s11606-020-06589-1
DO - 10.1007/s11606-020-06589-1
M3 - Article
C2 - 33506388
AN - SCOPUS:85099936557
SN - 0884-8734
VL - 36
SP - 3395
EP - 3401
JO - Journal of general internal medicine
JF - Journal of general internal medicine
IS - 11
ER -